Cargando…
Pharmacy Compounding Primer for Physicians: Prescriber Beware
Since the development of federal standards for drug approval, the practice of medicine has historically involved the compounding of medications based on a physician’s determination that a US FDA-approved product either did not exist, or could not be used for medical reasons. Today, prescriptions for...
Autores principales: | Sellers, Sarah, Utian, Wulf H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695671/ https://www.ncbi.nlm.nih.gov/pubmed/23039281 http://dx.doi.org/10.2165/11640850-000000000-00000 |
Ejemplares similares
-
Potential Risks of Pharmacy Compounding
por: Gudeman, Jennifer, et al.
Publicado: (2013) -
Assessing the Safety of COVID-19 Vaccines: A Primer
por: Petousis-Harris, Helen
Publicado: (2020) -
Antimicrobial Agents are Societal Drugs: How Should This Influence Prescribing?
por: Sarkar, Paul, et al.
Publicado: (2012) -
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
por: Sultana, Janet, et al.
Publicado: (2020) -
Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
por: Randles, Mary A., et al.
Publicado: (2022)